Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Hiroto Oshima"'
Autor:
Tatsuya Sato, Hiroto Oshima, Kei Nakata, Yukishige Kimura, Toshiyuki Yano, Masato Furuhashi, Masaya Tanno, Takayuki Miki, Tetsuji Miura
Publikováno v:
Journal of Diabetes Investigation, Vol 10, Iss 3, Pp 846-850 (2019)
Abstract The present study evaluated the accuracy of interstitial glucose measurements by flash glucose monitoring (FGM) and continuous glucose monitoring (CGM). Five diabetes patients simultaneously underwent FGM (FreeStyle Libre Pro) and CGM (iPro
Externí odkaz:
https://doaj.org/article/917a744d92ad44ef874e122edb2f017b
Autor:
Tatsuya Sato, Hiroto Oshima, Kei Nakata, Yukishige Kimura, Toshiyuki Yano, Masato Furuhashi, Masaya Tannno, Takayuki Miki, Tetsuji Miura
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 1, Pp 256-256 (2020)
Externí odkaz:
https://doaj.org/article/e7e0329abcbc4765bf986bb1d0637822
Autor:
Kei Nakata, Takayuki Miki, Masaya Tanno, Hirofumi Ohnishi, Toshiyuki Yano, Atsuko Muranaka, Tatsuya Sato, Hiroto Oshima, Yuki Tatekoshi, Masashi Mizuno, Koki Abe, Tetsuji Miura
Publikováno v:
PLoS ONE, Vol 12, Iss 12, p e0188689 (2017)
Sleep-disordered breathing (SDB) is highly prevalent in patients with diabetes mellitus (DM) and heart failure (HF) and contributes to poor cardiovascular outcomes. Enlarged glycemic variability (GV) is a risk factor of cardiac events independently o
Externí odkaz:
https://doaj.org/article/39056c8fdfe64be48f79b9f7a3388d5d
Autor:
Arata Osanami, Toshiyuki Yano, Masaki Shimizu, Yuki Tatekoshi, T Sato, Hidemichi Kouzu, Wataru Ohwada, Atsushi Kuno, Tetsuji Miura, Masaya Tanno, Masashi Mizuno, S Ino, Yugo Fujita, Toshifumi Ogawa, Hiroto Oshima
Publikováno v:
European Heart Journal. 42
Background A metabolomic study in the human heart suggested a pivotal role of amino acid (AA) metabolism in fatty acid oxidation, which is dysregulated in type 2 diabetes mellitus (T2DM) and heart failure. We previously reported that aberrant up-regu
Autor:
Hidemichi Kouzu, Yugo Fujita, Toshiyuki Yano, Arata Osanami, Toshifumi Ogawa, Hirohito Sugawara, Masashi Mizuno, Tetsuji Miura, Masaya Tannno, Hiroto Oshima, Atsushi Kuno, Takayuki Miki, Yusuke Igaki, T Sato, Yuki Tatekoshi
Publikováno v:
European Heart Journal. 41
Background Dysregulation of branched-chain amino acid (BCAA) metabolism has been shown to be associated with type 2 diabetes mellitus (T2DM) and heart failure. BCAA reportedly protects cells from fatty acid-induced mitochondrial injury via sequestrat
Publikováno v:
MobileHCI (Extended Abstracts)
Although the processing speed of computers is fast enough, users still have to wait for computers to complete tasks or respond. To cope with this, several types of visual information have been proposed as methods of presenting the current processing
Autor:
Marenao Tanaka, Yukishige Kimura, Hiroto Oshima, Tatsuya Sato, Norihito Moniwa, Atsushi Kuno, Tetsuji Miura, Takayuki Miki, Masashi Mizuno, Masaya Tanno, Toshiyuki Yano
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Acute kidney injury (AKI) predicts poor prognosis in patients with acute myocardial infarction (MI) and diabetes mellitus (DM) is an independent risk factor of AKI. Recent clinical studies have shown the beneficial effects of sodium-glucose cotranspo
Autor:
Hiroto Oshima, Atsushi Kuno, Tetsuji Miura, T Sato, Takayuki Miki, Masaya Tanno, Toshiyuki Yano, Hidemichi Kouzu
Publikováno v:
European Heart Journal. 41
Funding Acknowledgements Boehringer Ingelheim Background Although emerging evidence has indicated that sodium glucose cotransporter 2 (SGLT2) inhibitors restore impaired cardiac energetics in type 2 diabetes mellitus (T2DM), the underlying molecular
Autor:
Tatsuya Sato, Toshiyuki Yano, Masashi Mizuno, Koki Abe, Masaya Tanno, Tetsuji Miura, Hiroto Oshima, Atsushi Kuno, Takayuki Miki, Yukishige Kimura, Kei Nakata, Wataru Ohwada
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 368:524-534
The mechanism by which SGLT2 inhibitors reduce cardiac events in diabetic patients remains unclear. Here, we examined the effects of an SGLT2 inhibitor on the acute survival rate after myocardial infarction (MI) in an animal model of type 2 diabetes
Autor:
Tetsuji Miura, Atsushi Kuno, Masaya Tanno, Takayuki Miki, Masashi Mizuno, Kei Nakata, Yukishige Kimura, Hiroto Oshima, Toshiyuki Yano, Tatsuya Sato
Publikováno v:
Physiological Reports
To explore mechanisms by which SGLT2 inhibitors protect diabetic hearts from heart failure, we examined the effect of empagliflozin (Empa) on the ultrastructure of cardiomyocytes in the noninfarcted region of the diabetic heart after myocardial infar